Literature DB >> 1380457

Effects of Captan on DNA and DNA metabolic processes in human diploid fibroblasts.

R D Snyder1.   

Abstract

The fungicide Captan has been examined for its effects on DNA and DNA processing in order to better understand the genotoxicity associated with this agent. Captan treatment resulted in production of DNA single strand breaks and DNA-protein cross-links and elicited an excision repair response in human diploid fibroblasts. Captan was also shown to inhibit cellular DNA synthesis and to form stable adducts in herring sperm and human cellular DNA. Misincorporation of nucleotides into Captan-treated synthetic DNA templates was significantly elevated in an in vitro assay using E. coli DNA polymerase I, suggesting that DNA adduct formation by Captan could have mutagenic consequences. In sum, these studies demonstrate that Captan is capable of interacting with DNA at a number of levels and that these interactions could provide the basis for Captan's genotoxicity. The extreme cytotoxicity of this fungicide, however, could be due to other cellular effects since at the IC50 for cell killing, approximately 0.8 microM, none of the above genotoxic events could be detected by the methods employed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380457     DOI: 10.1002/em.2850200208

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  2 in total

1.  Urine mutagenicity and lymphocyte DNA damage in fruit growers occupationally exposed to the fungicide captan.

Authors:  P Lebailly; A Devaux; D Pottier; M De Meo; V Andre; I Baldi; F Severin; J Bernaud; B Durand; M Henry-Amar; P Gauduchon
Journal:  Occup Environ Med       Date:  2003-12       Impact factor: 4.402

2.  Characterization of two genes involved in chromate resistance in a Cr(VI)-hyper-resistant bacterium.

Authors:  Francesca Decorosi; Enrico Tatti; Annalisa Mini; Luciana Giovannetti; Carlo Viti
Journal:  Extremophiles       Date:  2009-09-19       Impact factor: 2.395

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.